Literature DB >> 16113633

Increased oxidative DNA damage, 8-hydroxydeoxy- guanosine, in human pterygium.

H-C Kau1, C-C Tsai, C-F Lee, S-C Kao, W-M Hsu, J-H Liu, Y-H Wei.   

Abstract

PURPOSE: Chronic exposure to ultraviolet (UV) light is a widely accepted aetiological factor in the development of pterygium. UV radiation may induce production of reactive oxygen species via photosensitized oxidation, thus causing oxidative damage. This study was conducted to test the hypothesis that oxidative damage to DNA is increased in pterygium.
METHODS: Immunohistochemical analysis employing a monoclonal antibody specific for 8-hydroxy-2'-deoxyguanosine (8-OHdG), a ubiquitous maker of oxidative stress, was performed in three patients with primary pterygium. The levels of 8-OHdG in DNA isolated from the other 29 pterygium specimens and their adjacent normal conjunctival tissues were determined using enzyme-linked immunosorbent assay (ELISA).
RESULTS: Immunohistochemistry of 8-OHdG showed a distinct pattern of more extensive and intense staining in the nuclei of pterygium tissue compared with that in their adjacent normal conjunctiva. ELISA also revealed that the average level of 8-OHdG in the pterygium tissues was 4.7-fold higher than that of the corresponding normal conjunctiva (P<0.001).
CONCLUSIONS: The increased levels of 8-OHdG in the pterygium tissues indicate that oxidative stress could play a role in the development of pterygium. These findings provide new information to better understand the pathogenesis of pterygium and are useful in the prevention and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113633     DOI: 10.1038/sj.eye.6702064

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  25 in total

1.  Pterygium.

Authors:  A S Solomon
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

Review 2.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

Review 3.  The role of heredity in pterygium development.

Authors:  Peter Anguria; James Kitinya; Sam Ntuli; Trevor Carmichael
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

4.  Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways.

Authors:  Chongshan Dai; Jichang Li; Shusheng Tang; Jian Li; Xilong Xiao
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

5.  Essential role of ultraviolet radiation in the decrease of corneal endothelial cell density caused by pterygium.

Authors:  Xia Li; Yiqin Dai; Weiwei Xu; Jianjiang Xu
Journal:  Eye (Lond)       Date:  2018-08-29       Impact factor: 3.775

6.  Peroxiredoxin I and II in human eyes: cellular distribution and association with pterygium and DNA damage.

Authors:  Sonja Klebe; Thomas Callahan; John H T Power
Journal:  J Histochem Cytochem       Date:  2013-10-23       Impact factor: 2.479

7.  Detection of 8-hydroxydeoxyguanosine enzyme in recurrent pterygium raising a question on its role on recurrence.

Authors:  Omar M S Ismaeel; Hasnan Jaafar; Mohtar Ibrahim
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

8.  Immunohistochemical detection of Hsp90 and Ki-67 in pterygium.

Authors:  Roberto Sebastiá; Marcelo Palis Ventura; Helena Parente Solari; Emilia Antecka; Maria Eugenia Orellana; Miguel N Burnier
Journal:  Diagn Pathol       Date:  2013-02-21       Impact factor: 2.644

9.  Evaluation of Primary Pterygia on Basis of the Loss of Vertical Length of Plica Semilunaris.

Authors:  Minjeong Kim; Yeoun Sook Chun; Kyoung Woo Kim
Journal:  Transl Vis Sci Technol       Date:  2021-07-01       Impact factor: 3.283

10.  4-Hydroxyhexenal- and 4-hydroxynonenal-modified proteins in pterygia.

Authors:  Ichiya Sano; Sachiko Kaidzu; Masaki Tanito; Katsunori Hara; Tsutomu Okuno; Akihiro Ohira
Journal:  Oxid Med Cell Longev       Date:  2013-05-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.